Cargando…

Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID‐19 and associated with neurological symptoms and disease severity

BACKGROUND AND PURPOSE: Neurological symptoms have been frequently reported in hospitalized patients with coronavirus disease 2019 (COVID‐19), and biomarkers of central nervous system (CNS) injury are reported to be increased in plasma but not extensively studied in cerebrospinal fluid (CSF). This s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virhammar, Johan, Nääs, Anja, Fällmar, David, Cunningham, Janet L., Klang, Andrea, Ashton, Nicholas J., Jackmann, Sven, Westman, Gabriel, Frithiof, Robert, Blennow, Kaj, Zetterberg, Henrik, Kumlien, Eva, Rostami, Elham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518988/ https://www.ncbi.nlm.nih.gov/pubmed/33369818 http://dx.doi.org/10.1111/ene.14703

Ejemplares similares

The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care
por: Fällmar, David, et al.
Publicado: (2022)

Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms
por: Cunningham, Janet L, et al.
Publicado: (2021)

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
por: Frithiof, Robert, et al.
Publicado: (2021)

Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid
por: Virhammar, Johan, et al.
Publicado: (2020)

Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid – the Gothenburg HIV CSF Study Cohort
por: Hagberg, Lars, et al.
Publicado: (2023)

Protein Expression Profile of ACE2 in the Normal and COVID-19-Affected Human Brain
por: Lindskog, Cecilia, et al.
Publicado: (2022)

Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study
por: Bromander, Sara, et al.
Publicado: (2012)

Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
por: Tyrberg, Tobias, et al.
Publicado: (2020)

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
por: Braun, Madelene, et al.
Publicado: (2022)

Cerebrospinal fluid findings of infant tuberculous meningitis: a scoping review
por: Hou, Jie, et al.
Publicado: (2022)

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
por: Yilmaz, Aylin, et al.
Publicado: (2019)

Relationship between catheter related cerebrospinal fluid infections and systemic immune-inflammation index
por: Nergiz, Sebnem, et al.
Publicado: (2023)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Identifying risk factors for neurological complications and monitoring long-term neurological sequelae: protocol for the Guangzhou prospective cohort study on hand-foot-and-mouth disease
por: Li, Kuanrong, et al.
Publicado: (2019)

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: The NeuroCOVID‐19 Task Force of the European Academy of Neurology
por: Sellner, Johann, et al.
Publicado: (2021)

Miller‐Fisher syndrome after COVID‐19: neurochemical markers as an early sign of nervous system involvement
por: Senel, M., et al.
Publicado: (2020)

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
por: Rass, Verena, et al.
Publicado: (2022)

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study
por: Rass, Verena, et al.
Publicado: (2021)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
por: Andreasson, Ulf, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
por: Tobieson, Lovisa, et al.
Publicado: (2021)

Estimating Hidden Population Sizes with Venue-based Sampling: Extensions of the Generalized Network Scale-up Estimator
por: Verdery, Ashton M., et al.
Publicado: (2019)

Complete Spinal Cord Injury Secondary to Serratia marcescens Spinal Epidural Abscess: A Report of Significant Neurological Improvement After a Delayed Presentation
por: Gall, Ashley, et al.
Publicado: (2023)

An Unusual Case of Concurrent Herpes Simplex Virus Type 1 and Cytomegalovirus Encephalitis Complicated by Primary Central Nervous System Lymphoma as an Initial Presentation of Acquired Immunodeficiency Syndrome
por: Findakly, Dawood
Publicado: (2021)

Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS
por: Hölttä, Mikko, et al.
Publicado: (2012)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: A critical systematic review
por: Cosentino, Giuseppe, et al.
Publicado: (2021)

Dutch multicentre, prospective follow-up, cohort study comparing the neurological and neuropsychological sequelae of hospitalised non-ICU- and ICU-treated COVID-19 survivors: a study protocol
por: Klinkhammer, Simona, et al.
Publicado: (2021)

Assessing the Dynamics of COVID-19 Morbidity and Mortality in Response to Mass Vaccination: A Comparative Study Between Saudi Arabia and the United Kingdom
por: Khatrawi, Elham M, et al.
Publicado: (2022)

Focal Neurological Symptoms at Initial Presentation Could Be a Potential Risk Factor for Poor Prognosis Among Patients With Multiple Brain Abscesses by Streptococcus anginosus Group: A Case Report With Literature Review
por: Shibamura, Natsuki, et al.
Publicado: (2022)

Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability
por: Simrén, Joel, et al.
Publicado: (2022)

Sequential Imaging Characteristics and Potential Role of F18 Fluorodeoxyglucose Positron Emission Tomography/CT in the Evaluation of Treatment Response in Cases of Spinal Tuberculosis Without Neurological Involvement: Results From a Pilot Study
por: Rai, Ankit, et al.
Publicado: (2022)

Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study
por: Turner, P, et al.
Publicado: (2013)

Cerebrospinal fluid proteome maps detect pathogen-specific host response patterns in meningitis
por: Bakochi, Anahita, et al.
Publicado: (2021)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

The effect of community-acquired bacteraemia on return to workforce, risk of sick leave, permanent disability pension and death: a Danish population-based cohort study
por: Dalager-Pedersen, Michael, et al.
Publicado: (2014)

Neurological Involvement Complicating Invasive Pulmonary Aspergillosis
por: Diallo, Ibrahima Dokal, et al.
Publicado: (2022)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
por: Stomrud, Erik, et al.
Publicado: (2015)

Salmonella Sternoclavicular Septic Arthritis in a Non-sickle Cell Disease Patient
por: Alghamdi, Hind M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nig7b881g7vbgsf4t5qrofo19v